Denali Therapeutics Inc. (DNLI)
NASDAQ: DNLI · Real-Time Price · USD
18.74
-0.15 (-0.79%)
Nov 13, 2026, 4:00 PM EST - Market closed

Denali Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
102.87205.33174.96127.11218.04293.48
Short-Term Investments
413.33662.55657.37907.411,118571.93
Cash & Short-Term Investments
516.2867.88832.331,0351,336865.41
Cash Growth
-39.14%4.27%-19.54%-22.58%54.40%-41.12%
Accounts Receivable
18.882.182.173.429.28-
Other Receivables
-----1.23
Receivables
18.882.182.173.429.281.23
Prepaid Expenses
30.3630.629.9326.2126.8230.6
Total Current Assets
591.71900.66864.441,0641,372897.23
Property, Plant & Equipment
109.3119.94125.6371.6474.5269.61
Long-Term Investments
506.38113.32374.37--425.45
Other Long-Term Assets
14.1510.949.7418.1413.411.87
Total Assets
1,2561,1451,3741,1541,4601,404

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
13.73.3311.149.482.794.78
Accrued Expenses
54.6364.3764.9161.2459.3747.71
Current Portion of Leases
10.519.5512.037.267.325.45
Current Unearned Revenue
----290.05320.3
Other Current Liabilities
16.4221.114.13-4.39-
Total Current Liabilities
95.2698.35102.2177.98363.92378.25
Long-Term Leases
24.7332.7442.2944.9853.0358.55
Long-Term Unearned Revenue
----0.484.69
Other Long-Term Liabilities
209.66---0.380.38
Total Liabilities
329.65131.09144.5122.96417.81441.87

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
1.931.891.771.711.691.55
Additional Paid-In Capital
3,1683,0632,7652,1452,0191,608
Retained Earnings
-2,237-2,052-1,539-1,116-970.99-645
Comprehensive Income & Other
-6.360.682.020.64-6.89-2.5
Total Common Equity
926.391,0141,2301,0311,042962.29
Shareholders' Equity
926.391,0141,2301,0311,042962.29
Total Liabilities & Equity
1,2561,1451,3741,1541,4601,404

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
35.2442.2954.3252.2460.3564.01
Net Cash (Debt)
972.33923.911,137982.271,2761,227
Net Cash Growth
17.37%-18.77%15.79%-23.01%4.00%-14.42%
Net Cash Per Share
5.275.356.927.1510.1610.10
Filing Date Shares Outstanding
160.29158.59145.22139.16136.68122.83
Total Common Shares Outstanding
160.26156.18144.22138.39135.97122.28
Working Capital
496.45802.31762.23986.161,008518.99
Book Value Per Share
5.786.498.537.457.677.87
Tangible Book Value
891.891,0141,2301,0311,042962.29
Tangible Book Value Per Share
5.576.498.537.457.677.87
Machinery
-67.5460.3750.3537.632.97
Leasehold Improvements
-47.7646.9141.2443.735.24
SEC Filings: 10-K · 10-Q